pomegranate log AUC differences, using a linear model with age group, sex, and their interaction as predictors, revealed a significant age sex interaction on the intervention effect ( P = 0.004), indicating that the identified difference by age varied with participant sex
They might start with 1,000 mcg daily for a week
What the evidence supports: BPC-157 consistently improves tendon healing outcomes in animal models across multiple tissue types and injury models TB-500 accelerates wound healing and tissue repair in preclinical studies with measurable improvements in re-epithelialization, collagen deposition, and angiogenesis GHK-Cu enhances collagen synthesis and modulates thousands of genes involved in tissue repair GHRP-2 shifts macrophage polarization favorably in a rotator cuff tear model Relaxin-2 eliminates capsular fibrosis in a frozen shoulder mouse model No significant toxicity has been identified in preclinical BPC-157 studies What remains uncertain: Whether animal study results translate to equivalent human outcomes for shoulder conditions specifically Optimal dosing for human shoulder injuries (all protocols are extrapolated from animal data and clinical observation) Long-term safety with repeated use Whether peptides meaningfully reduce rotator cuff retear rates after surgical repair in humans How peptide therapy compares to established treatments like PRP in controlled human studies Potential interactions with medications commonly used by shoulder pain patients What we need: Randomized controlled trials of BPC-157 and TB-500 for specific shoulder conditions in humans Head-to-head comparisons of peptide therapy versus established treatments Long-term safety data from monitored human use Standardized dosing protocols based on human pharmacokinetic data Studies combining peptides with rehabilitation to assess synergistic effects The preclinical evidence is compelling
Since skin cells take approximately 28 to 40 days to turn over, visible results such as increased brightness or a more even tone typically take between 8 and 12 weeks of consistent use
16,17 Hence, mechanistic studies indicate that oral semaglutide parks in the stomach, where it is then absorbed in a localized fashion with the help of the absorption enhancer sodium N -[8 (2-hydroxylbenzoyl) amino] caprylate (SNAC)
